Introduction

The integration of nanotechnology into periodontal therapy represents a significant advancement in the management of periodontal disease, a chronic inflammatory condition characterized by the destruction of the dental attachment apparatus. Traditional surgical management of periodontal disease, which includes procedures like scaling, root planning, and flap surgery, aims to halt disease progression and promote tissue regeneration. However, these methods often face limitations in achieving complete regeneration of periodontal tissues. Nanotechnology offers a promising avenue to overcome these challenges by enhancing drug delivery, diagnostics, and tissue engineering in periodontal therapy. This review paper explores the potential of nanotechnology to modulate the periodontal microenvironment, thereby improving surgical outcomes and advancing periodontal treatment strategies.

Periodontal disease is a multifactorial inflammatory condition that leads to the destruction of periodontal tissues, including the cementum, periodontal ligament, and alveolar bone [1, 2]. Traditional surgical management techniques, such as scaling, root planning, and periodontal flap surgery, aim to remove plaque and calculus, reduce inflammation, and promote tissue regeneration [2, 3]. Despite their effectiveness, these methods often fall short of achieving complete tissue regeneration, necessitating the exploration of advanced therapeutic approaches [2].

The periodontal microenvironment is complex, involving interactions between host tissues, biofilm pathogens, and inflammatory mediators [2]. Modulating this environment can enhance the effectiveness of periodontal therapies by targeting specific pathogens and inflammatory pathways[4]. Nanotechnology provides tools for precise modulation of the microenvironment, enabling targeted drug delivery and controlled release of therapeutic agents [2].

Nanotechnology enables the development of nanoparticles and nanorobots that can deliver drugs directly to periodontal pockets, improving therapeutic outcomes [1, 3]. Nanomaterials, such as nanofibers and nanoscaffolds, support tissue regeneration by providing structural support and enhancing cellular interactions [2, 5]. Diagnostic advancements, including nano-scale biosensors, allow for early detection and monitoring of periodontal disease, facilitating timely intervention [3, 6]. The use of nanotechnology in periodontal therapy is associated with reduced side effects and improved patient compliance due to its precision and efficiency [6].

While the integration of nanotechnology into periodontal therapy holds great promise, it is essential to consider the challenges and limitations associated with its application. These include the potential for toxicity, the complexity of manufacturing nanomaterials, and the need for extensive clinical trials to establish safety and efficacy. Additionally, the cost of nanotechnology-based treatments may pose a barrier to widespread adoption. Despite these challenges, ongoing research and technological advancements continue to drive the evolution of nanotechnology in periodontal therapy, offering new opportunities for improving patient outcomes and advancing the field of periodontics.

The Periodontal Microenvironment in Health and Disease

The periodontal microenvironment is a complex and dynamic system vital for maintaining oral health, significantly influenced by disease and surgical interventions, and is composed of various cellular components such as fibroblasts, osteoblasts, and periodontal ligament stem cells (PDLSCs) that sustain tissue homeostasis and regeneration[7, 8], alongside molecular components including cytokines, growth factors, and extracellular matrix proteins that regulate inflammation and tissue repair through a balance of pro- and anti-inflammatory signals[8, 9]. Nanomaterials can modulate these cellular and molecular components by enhancing drug delivery and promoting tissue regeneration. For instance, nanoparticles can deliver anti-inflammatory agents directly to the site of inflammation, improving therapeutic outcomes [1].

Surgical procedures like scaling and root planning can disrupt this environment temporarily, causing inflammation and tissue damage, yet they also aim to remove diseased tissue and foster healing, with nanotechnology enhancing regenerative potential by providing scaffolds for cell adhesion and proliferation as well as enabling targeted delivery of growth factors and anti-inflammatory agents through nanoparticles that improve therapeutic outcomes [7, 9, 10]. Incorporating nanomaterials into surgical treatments can improve outcomes by creating a more favorable environment for tissue regeneration. For example, nanocarriers can deliver growth factors to enhance osteogenesis and periodontal ligament regeneration [2, 11].

Periodontal disease pathogenesis involves chronic inflammation driven by a dysbiotic biofilm and an exaggerated immune response, causing tissue destruction[1, 2], while barriers to regeneration include ongoing inflammation, poor blood supply, and complex tissue architecture that impede full restoration[9]; nanotechnology addresses these challenges via engineered drug delivery systems responsive to environmental triggers to modulate inflammation and boost tissue regeneration[8]. Despite the promising role of nanomaterials in modulating the periodontal microenvironment and advancing treatment strategies, concerns remain regarding their long-term safety and biocompatibility, highlighting the need for further research and a multifaceted therapeutic approach that integrates both traditional and novel methods for optimal periodontal disease management[7, 12].

Fundamentals of Nanotechnology in Dentistry

Nanotechnology in dentistry, particularly in periodontal therapy, represents a transformative approach that exploits the unique properties of materials at the nanoscale (1–100 nanometers) to enhance treatment outcomes by enabling precise, targeted, and efficient modalities; it is based on core principles such as molecular self-assembly, precise control of chemical characteristics, and the development of nanoparticles with specific functionalities to interact with biological systems at the molecular level[13].

Various types of nanomaterials are used in periodontal applications, including inorganic nanoparticles like silver, gold, and zinc oxide that provide potent antimicrobial effects against bacterial infections in periodontal pockets; organic nanoparticles such as polymeric nanoparticles and liposomes that serve as drug delivery systems for localized therapy; and nanocomposites like nanofibers, hydrogels, and membranes which act as scaffolds to promote tissue regeneration and repair of periodontal structures. These nanomaterials are attractive for periodontal therapy due to their antimicrobial, anti-inflammatory, and antioxidant properties crucial for controlling infection and inflammation, as well as their regenerative capabilities that support bone and soft tissue healing, targeted drug delivery potential that reduces systemic side effects and enhances efficacy, and their utility in diagnostic and monitoring tools such as nanoscale biosensors that detect pathogens and track treatment progress in real time[1, 13, 14]. Despite these promising advancements, challenges remain regarding cytotoxicity, stability, and the translation of positive in vitro findings into safe and effective in vivo clinical applications, necessitating ongoing research; furthermore, emerging nanotechnologies like nanorobots, still experimental, hold future potential for revolutionary periodontal diagnostics and therapies. Overall, the integration of nanotechnology into periodontal treatment is poised to significantly improve patient outcomes by advancing precision medicine approaches in periodontics[3, 15].

Nanotechnology-Based Modulation of the Periodontal Microenvironment

Nanotechnology offers promising strategies for modulating the periodontal microenvironment, particularly in the context of surgical treatment for periodontitis. The unique properties of nanomaterials, such as their small size and high surface area, enable them to interact effectively with periodontal tissues, providing antibacterial, anti-inflammatory, and antioxidant benefits that are crucial for disrupting biofilms, modulating immune responses, and controlling oxidative stress, all essential for successful periodontal therapy. Nanoparticles can penetrate and disrupt biofilms, overcoming limitations of conventional treatments due to biofilm resilience by interacting with bacterial membranes to induce cell lysis and death[16], while specific nanocomposites incorporating antimicrobial peptides enhance photodynamic therapy efficacy[14, 16]. Additionally, nanoparticles modulate immune responses by inhibiting inflammatory pathways like NF-κB and promoting tissue regeneration[17, 18]; dynamic covalent nanonetworks absorb pathogen-associated molecular patterns and scavenge reactive oxygen species (ROS), thus regulating local immunity[19]. Nanomaterials also reduce oxidative stress by scavenging ROS, overproduced in periodontitis[18, 20], and controlled-release nanoparticles such as MitoQ@PssL regulate the ROS-PINK1-Parkin pathway to enhance mitophagy and reduce oxidative damage[20]. Targeted drug delivery and controlled release platforms enable the delivery of therapeutics directly to periodontal tissues, improving outcomes and minimizing side effects[1], with ROS-responsive polymers ensuring drug release in response to microenvironmental triggers[20]. Furthermore, nanomaterials serve
as scaffolds supporting cellular adhesion, proliferation, and differentiation, promoting tissue regeneration. Despite these advantages, challenges such as potential nanoparticle toxicity, discrepancies between in vitro and in vivo results, and translation from animal models to human application must be addressed to ensure clinical safety and efficacy[14]. The development of multifunctional nanocomposites combining antimicrobial, anti-inflammatory, and regenerative properties presents a comprehensive approach to managing periodontitis and enhancing treatment outcomes.

Nanomaterials in Surgical Periodontal Regeneration

Nanotechnology has significantly advanced the field of periodontal regeneration by offering innovative solutions through nanofibers, hydrogels, membranes, and scaffolds, which enhance tissue regeneration by providing a conducive microenvironment for cellular adhesion, proliferation, and differentiation. Nanofibers mimic the natural extracellular matrix and are particularly effective in intrapocket administration, improving mucoadhesion and retention time to accelerate wound healing and osteogenesis[21]. Hydrogels and membranes made from biocompatible polymers maintain a moist environment that supports cell migration and differentiation, essential for tissue regeneration[10], while nanomaterial-based scaffolds such as those composed of nanohydroxyapatite and polycaprolactone enhance structural integrity and functionality, facilitating regeneration of bone and periodontal ligaments[22, 23]. Specifically, nanohydroxyapatite composites promote osteogenesis by providing a biomimetic surface, encouraging bone cell activity[22]; nanomaterials support cementogenesis by enabling deposition of cementum-like tissues vital for periodontal ligament attachment[7]; and nanostructured scaffolds drive periodontal ligament regeneration by fostering progenitor cell differentiation into ligament-forming cells, restoring periodontium architecture[24]. The integration of nanotechnology with conventional surgical techniques synergistically improves periodontal treatment outcomes by enabling sustained release of therapeutics, precise targeting of periodontal defects, reducing invasiveness, and enhancing patient recovery[25]. This combined approach effectively addresses limitations of traditional methods, such as limited regeneration capacity and high disease recurrence rates. Table 1 summarizes the main strategies, materials, mechanisms, and clinical advantages of nanotechnology for periodontal regeneration.

However, despite these benefits, challenges remain, including the need for standardization of nanomaterials, ensuring their long-term safety, and understanding interactions within biological environments, all of which are critical for the safe and widespread clinical adoption of nanotechnology-based periodontal regeneration therapies.

Types of Nanomaterials in Periodontal Therapy

Nanotechnology has emerged as a transformative approach in periodontal therapy, offering innovative solutions to modulate the periodontal microenvironment, particularly in surgical treatments. The application of nanomaterials in this field is categorized into three main types: inorganic nanoparticles, organic nanoparticles, and composite and smart biomaterials. Each category presents unique properties and advantages that contribute to the enhancement of periodontal treatment outcomes. The following sections delve into these categories, highlighting their specific roles and benefits in periodontal therapy.

Inorganic nanoparticles, including silver, gold, and metal oxide variants, have gained significant attention in periodontal therapy due to their dual functions in combating infections and facilitating tissue repair. Silver nanoparticles are particularly effective because of their strong antibacterial capabilities, which enable them to damage bacterial cell membranes and decrease the presence of harmful periodontal microbes[14, 26]. Gold nanoparticles are prized for their excellent biocompatibility and their capacity to support bone regeneration by promoting osteogenic differentiation, a key process in periodontal healing[27]. Additionally, metal oxide nanoparticles such as zinc oxide and titanium dioxide contribute valuable antimicrobial and anti-inflammatory effects, helping to alleviate periodontal inflammation and enhance tissue recovery[27, 28].

Organic nanoparticles, such as those derived from chitosan and biodegradable polymers like PLA and PLGA, have become prominent in periodontal therapy due to their favorable biocompatibility and biodegradability. Chitosan nanoparticles are particularly valued for their antimicrobial activity combined with mucoadhesive properties, which help prolong drug retention within periodontal pockets and consequently enhance treatment efficacy [27]. Meanwhile, biodegradable polymers such as polylactic acid (PLA) and polylactic-co-glycolic acid (PLGA) serve as versatile carriers for controlled drug delivery, enabling sustained release of therapeutics over extended periods and reducing the frequency of administration necessary for effective periodontal management [26].

Composite and smart biomaterials represent a cutting-edge approach in periodontal regeneration by combining diverse functionalities to enhance therapeutic outcomes. Nanocomposites integrate nanoparticles within polymeric or other matrices, thereby improving mechanical strength and facilitating targeted drug delivery, which collectively support more effective periodontal tissue repair. Smart biomaterials are designed to respond to specific environmental triggers such as pH or temperature fluctuations, enabling controlled and site-specific release of drugs, thus optimizing treatment precision and efficacy. Despite the promising potential of these nanotechnologies, challenges remain concerning their safety profile, including nanoparticle toxicity and environmental concerns[14]. Moreover, translating promising laboratory findings into clinical practice requires addressing these issues alongside the establishment of standardized manufacturing protocols and regulatory frameworks to guide their safe and efficacious application in periodontal therapy[27].

Clinical Evidence and Translational Challenges

Nanotechnology has been widely explored in both preclinical and clinical contexts for its ability to improve periodontal treatment outcomes. Preclinical investigations have consistently demonstrated that nanoparticles can effectively deliver therapeutic agents to periodontal tissues, thereby increasing drug bioavailability and facilitating tissue regeneration. These nanoparticles exhibit multiple beneficial properties, including antibacterial, anti-inflammatory, and bone-promoting effects, all of which are essential for successful periodontal repair [1, 14]. Although clinical research in this field remains limited, early-stage trials have reported encouraging results, showing that nanoparticle-based interventions can enhance healing following periodontal surgeries and alleviate inflammation. Collectively, these findings underscore the promising role of nanotechnology in advancing periodontal therapy, while also indicating the need for further clinical validation [25, 29].

The clinical use of nanoparticles necessitates a thorough evaluation of their safety and biocompatibility to minimize potential risks to patients. A key concern is the possibility of toxic accumulation within cells, which could lead to detrimental cellular effects; thus, the careful design and rigorous preclinical testing of nanoparticles are paramount to ensure their safety profile[14, 29]. Additionally, ensuring that nanoparticles exhibit high biocompatibility with human tissues is critical for their successful long-term use. Research efforts have been directed toward developing nanoparticles that not only deliver therapeutic benefits effectively but also avoid triggering adverse immune reactions, promoting their acceptance and integration in clinical settings[29, 30].

Practice faces notable challenges that hinder its widespread adoption in periodontics. Frequently, findings from in vitro experiments and animal studies do not accurately predict outcomes in humans, highlighting a gap in the extrapolation of efficacy and safety data. This discrepancy poses a critical obstacle for the validation and approval of nanoparticle-based treatments. Furthermore, the regulatory environment governing nanomedicine is intricate and evolving, requiring rigorous demonstration that these novel materials satisfy stringent safety and therapeutic efficacy criteria set by health authorities [14, 29]. Navigating these regulatory hurdles including compliance with guidelines specific to nanomaterial characterization, toxicity, and clinical trial validation is essential to ensure patient safety and successful market entry [29, 30]. While the promise of nanotechnology in enhancing periodontal therapy is substantial, overcoming the challenges of translational fidelity and regulatory approval remains imperative for its integration into everyday clinical use.

Conclusion

Nanotechnology offers transformative potential in modulating the periodontal microenvironment, particularly in enhancing surgical treatments through targeted drug delivery, improved antibacterial and anti-inflammatory actions, and promotion of tissue regeneration. The nanoscale size and high surface area of nanoparticles enable precise therapeutic targeting to infected or inflamed sites, thereby maximizing efficacy while minimizing systemic side effects. Additionally, nanotechnology supports the advancement of innovative diagnostic tools and regenerative biomaterials, significantly contributing to improved clinical outcomes in periodontal therapy. Nonetheless, several challenges impede the full clinical translation of these technologies. Issues such as nanoparticle toxicity, inconsistent correlations between in vitro and in vivo findings, and difficulties in extrapolating animal model results to human patients remain critical barriers. Further complexities arise from regulatory constraints and concerns regarding the long-term stability and safety of nanomaterials. To harness the full benefits of nanotechnology in periodontics, future research must prioritize the development of biocompatible and safe nanomaterials, establish more predictive animal models, and promote clear regulatory frameworks. Additionally, fostering interdisciplinary collaboration and integrating nanotechnology with personalized treatment strategies stand to accelerate clinical adoption and optimize patient outcomes. Finally, addressing ethical, economic, and social considerations is essential to ensure equitable access and public trust as nanotechnology continues to evolve within periodontal care. A balanced approach combining innovation with rigorous safety and ethical oversight will be key to unlocking the promise of nanotechnology in revolutionizing periodontal therapy.

Acknowledgments

The authors utilized artificial intelligence tools, namely Perplexity.ai, to enhance the clarity and language quality of this manuscript during its preparation. All AI-generated suggestions and content were thoroughly reviewed and revised by the authors, who maintain full responsibility for the accuracy and integrity of the completed work.

Conflict of Interest

The authors declare that they have no conflicts of interest related to this work.